Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $119.3600 (0.45%) ($119.2200 - $120.4500) on Mon. Aug. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.92% (three month average) | RSI | 59 | Latest Price | $119.3600(0.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(44%) SPLV(35%) XLP(33%) VYM(32%) DIA(31%) | Factors Impacting ABBV price | ABBV will decline at least -0.46% in a week (0% probabilities). VIXM(-20%) UUP(-10%) VXX(-2%) TLT(-1%) KWEB(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.46% (StdDev 0.92%) | Hourly BBV | 0.9 () | Intraday Trend | -0.4% | | | |
|
5 Day Moving Average | $118.61(0.63%) | 10 Day Moving Average | $117.31(1.75%) | 20 Day Moving Average | $116.74(2.24%) | To recent high | -0.3% | To recent low | 7.1% | Market Cap | $210.585b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |